SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-17-004902
Filing Date
2017-08-09
Accepted
2017-08-09 15:13:32
Documents
55
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 a8417010q.htm 10-Q 883346
2 EXHIBIT 10.2 ex10_2.htm EX-10.2 43385
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 12531
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 12350
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 4012
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 3940
  Complete submission text file 0001214659-17-004902.txt   3872082

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT anth-20170630.xml EX-101.INS 639436
8 XBRL TAXONOMY EXTENSION SCHEMA anth-20170630.xsd EX-101.SCH 36777
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anth-20170630_cal.xml EX-101.CAL 39268
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anth-20170630_def.xml EX-101.DEF 189067
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE anth-20170630_lab.xml EX-101.LAB 300856
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anth-20170630_pre.xml EX-101.PRE 251125
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 171017615
SIC: 2834 Pharmaceutical Preparations